Cat. No. | Product name | CAS No. |
DC73920 |
BI-0955
BI-0955 is an inactive HSD17B13 control compound for BI-3231. |
|
DC73921 |
BI-9466
BI-9466 (BI 9466) is the negative control of NSD3-PWWP1 domain chemical probe BI-9321. |
2538293-52-4 |
DC73922 |
BiTud
BiTud is a bivalent inhibitor against TDRD3 with binding Kd of 6 uM for tandem Tudor chimera, blocks the recruitment of TDRD3 by the two methylated arginines of G3BP1, suppress the phase separation of methylated G3BP1, TDRD3, and RNAs, and in turn inhibit |
2758663-98-6 |
DC73923 |
BK697
BK697 is a small molecule targeting FIRΔexon2, potentially interacts with FIRΔexon2, significantly suppresses the FIRΔexon2 expression and inhibits tumor cell growth and several rRNA expressions. |
1839048-73-5 |
DC73924 |
BNZ-1
BNZ-1 (BNZ132-1-40) is a pegylated peptide, BNZ132-1 conjugated with methoxy-PEG40 maleimide molecule via a specific linker (CGSGG), specifically binds the γc receptor to selectively block IL-2, IL-15 and IL-9 signaling. |
|
DC73925 |
BNZ132-1
BNZ132-1 (QITISILSQINRVFHEKFI) is a specific peptide inhibitor for the IL-2/IL-15 subfamily, directly binds to the γc molecule (CD132). |
|
DC73926 |
BR102910
BR102910 (BR 102910) is a novel potent, selective, oral fibroblast activation protein (FAP) inhibitor with IC50 of 1 nM. |
2505339-54-6 |
DC73927 |
BRD4780
BRD4780 is a small molecule that releases MUC1-fs from TMED9-enriched compartments and promotes its anterograde trafficking to the lysosome, directly binds to TMED9. |
2568912-84-3 |
DC73928 |
BRD8518
BRD8518 is a specific small molecule TRIB1 inducer, modulates expression of the key genes involved in VLDL production and in LDL clearance in HepG2 cells. |
1565828-01-4 |
DC73929 |
BRM011
BRM011 (dual BRM and BRG1 inhibitor 11) is a potent, selective, allosteric dual BRM and BRG1 inhibitor with IC50 of <5 nM for both. |
2270875-79-9 |
DC73930 |
Butaselen
Butaselen is a small molecule inhibitor of thioredoxin reductase (TrxR)/thioredoxin (Trx) with anti-tumor activity, inhibits the growth of various human cancer cell lines. |
857375-83-8 |
DC73931 |
C105SR
C105SR is small-molecule cyclophilin inhibitor with IC50 of 5 nM for inhibition of CypD PPIase activity and 9 nM for mitochondrial swelling. |
|
DC73932 |
C10M
C10M is a small molecule inhibitor of C-reactive protein (CRP), inhibits the binding of pCRP to the physiological ligand phosphocholine (PC) with IC50 of 1.5 mM in ELISA assays. |
2824243-53-8 |
DC73933 |
C902
Featured
C902 is a small-molecule inhibitor targeting LIN28-let-7 interaction, shows dose-dependent inhibition in an EMSA validation assay with IC50 of 5 uM. |
1395472-39-5 |
DC73934 |
Calmirasone1
Calmirasone1 (Calmirasone 1) is a novel and potent covalent calmodulin (CaM) inhibitor with Kd of 0.87 uM. |
|
DC73935 |
CARD8 activator CQ31
CARD8 activator CQ31 is a small molecule that selectively activates CARD8. |
441022-67-9 |
DC73936 |
CASK chemical probe 18
CASK chemical probe 18 is a highly potent and selective CASK inhibitor with IC50 of 22 nM. |
2755241-73-5 |
DC73937 |
CB253
CB253 is a small molecule that selectively binds the hairpin form of r(G4C2)exp, inhibiting mechanisms that drive c9ALS/FTD pathobiology. |
1225169-17-4 |
DC73938 |
CBK034026C
CBK034026C is a small molecule targeting metabolic vulnerabilities caused by N-acetyltransferase 2 (NAT2) activity, exhibits specific toxicity towards colorectal cancer (CRC) cells with high NAT2 activity. |
|
DC73939 |
CBLC000
CBLC000 (CBL0100) is a small molecule histone chaperone FACT inhibitor, activates p53 and inhibits NF-κB with EC50 of 0.06 and 0.03 uM in cell-based p53 and NF-κB reporter assays, respecitvely. |
1197996-83-0 |
DC73940 |
CC-410
CC-410 (CC410) is a potent, specific inhibitor of nicotinamide N-methyltransferase (NNMT) with IC50 of 1.6 uM (human NNMT). |
636564-27-7 |
DC73941 |
CHD1Li 11
CHD1Li 11 (CHD1L inhibitor 11) is a small molecule inhibitor of chromodomain helicase DNA-binding protein 1 like (CHD1L) with IC50 of 4.57 uM. |
1015582-93-0 |